Influence of menstrual cycle and gender on alprazolam pharmacokinetics. 1991

C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
Virginia Commonwealth University, School of Pharmacy, Richmond 23298-0533.

The effects of menstrual cycle phases and gender on alprazolam pharmacokinetics were evaluated in normal volunteers. Alprazolam (1 mg) was administered to seven women during the late follicular and luteal phases of the menstrual cycle and to eight men on one occasion. No difference in alprazolam pharmacokinetic parameters was observed during the menstrual cycle phases. Mean alprazolam clearance (+/- SD) was 0.0037 +/- 0.0009 ml/hr during the follicular phase and 0.0036 +/- 0.001 ml/hr during the luteal phase (p greater than 0.05, difference not significant). With use of weight as a covariant, there was no difference in alprazolam pharmacokinetic parameters between women and men. Mean alprazolam clearance (+/- SD) was 0.0036 +/- 0.0009 ml/hr in women compared with 0.0041 +/- 0.0006 ml/hr in men (p greater than 0.05, difference not significant). Although alprazolam metabolism was similar on the 2 days tested, alterations may occur at other times during the menstrual cycle. Further investigation is needed to understand the effects of menstrual cycle phases and gender on drug metabolism.

UI MeSH Term Description Entries
D008183 Luteal Phase The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION. Menstrual Cycle, Luteal Phase,Menstrual Cycle, Secretory Phase,Menstrual Secretory Phase,Postovulatory Phase,Phase, Luteal,Phase, Postovulatory,Secretory Phase, Menstrual
D008297 Male Males
D008597 Menstrual Cycle The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase. Endometrial Cycle,Ovarian Cycle,Cycle, Endometrial,Cycle, Menstrual,Cycle, Ovarian,Cycles, Endometrial,Cycles, Menstrual,Cycles, Ovarian,Endometrial Cycles,Menstrual Cycles,Ovarian Cycles
D010060 Ovulation The discharge of an OVUM from a rupturing follicle in the OVARY. Ovulations
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D005260 Female Females
D005498 Follicular Phase The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION. Menstrual Cycle, Follicular Phase,Menstrual Cycle, Proliferative Phase,Menstrual Proliferative Phase,Preovulatory Phase,Phase, Follicular,Phase, Menstrual Proliferative,Phase, Preovulatory,Proliferative Phase, Menstrual
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
January 1990, European journal of clinical pharmacology,
C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
December 2008, Archives of oral biology,
C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
January 1996, The American journal of gastroenterology,
C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
July 2000, Journal of clinical pharmacology,
C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
January 2007, Clinical hemorheology and microcirculation,
C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
April 1999, European journal of clinical pharmacology,
C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
November 1988, British journal of clinical pharmacology,
C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
February 1990, The Journal of clinical endocrinology and metabolism,
C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
January 1983, Journal de gynecologie, obstetrique et biologie de la reproduction,
C Kirkwood, and A Moore, and P Hayes, and C L DeVane, and A Pelonero
August 2002, Therapeutic drug monitoring,
Copied contents to your clipboard!